How big is DMK Pharmaceuticals Corp.?

Jun 22 2025 06:00 PM IST
share
Share Via
As of Jun 18, DMK Pharmaceuticals Corp. has a market capitalization of 0.00, with net sales of 3.62 million and a net profit of -21.15 million over the latest four quarters. As of Dec 22, shareholder's funds are reported at -0.65 million, and total assets amount to 10.93 million.
As of Jun 18, DMK Pharmaceuticals Corp. has a market capitalization of 0.00, categorizing it as a Micro Cap company.

As of Jun 18, the sum of Net Sales for the latest four quarters is 3.62 million, while the sum of Net Profit for the same period is -21.15 million.

As of Dec 22, the Shareholder's Funds are reported at -0.65 million, and the Total Assets amount to 10.93 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is DMK Pharmaceuticals Corp. overvalued or undervalued?
Sep 20 2025 06:19 PM IST
share
Share Via
Is DMK Pharmaceuticals Corp. overvalued or undervalued?
Jun 25 2025 08:57 AM IST
share
Share Via